Literature DB >> 33504595

A new lease on life for an HIV-neutralizing antibody class and vaccine target.

Dennis R Burton1,2.   

Abstract

Year:  2021        PMID： 33504595      PMCID： PMC7896332          DOI： 10.1073/pnas.2026390118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

Review 1.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

2.  Enfuvirtide.

Authors:  Jason LaBonte; John Lebbos; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2003-05       Impact factor: 84.694

3.  A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope.

Authors:  Michael D Miller; Romas Geleziunas; Elisabetta Bianchi; Simon Lennard; Renee Hrin; Hangchun Zhang; Meiqing Lu; Zhiqiang An; Paolo Ingallinella; Marco Finotto; Marco Mattu; Adam C Finnefrock; David Bramhill; James Cook; Debra M Eckert; Richard Hampton; Mayuri Patel; Stephen Jarantow; Joseph Joyce; Gennaro Ciliberto; Riccardo Cortese; Ping Lu; William Strohl; William Schleif; Michael McElhaugh; Steven Lane; Christopher Lloyd; David Lowe; Jane Osbourn; Tristan Vaughan; Emilio Emini; Gaetano Barbato; Peter S Kim; Daria J Hazuda; John W Shiver; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

4.  Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.

Authors:  Vincent Holl; Maryse Peressin; Sylvie Schmidt; Thomas Decoville; Susan Zolla-Pazner; Anne-Marie Aubertin; Christiane Moog
Journal:  Blood       Date:  2006-02-09       Impact factor: 22.113

Review 5.  HIV entry and its inhibition.

Authors:  D C Chan; P S Kim
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

6.  Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.

Authors:  P J Klasse
Journal:  Adv Biol       Date:  2014-09-09

7.  A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge.

Authors:  Amarendra Pegu; Bhavesh Borate; Yunda Huang; Matthias G Pauthner; Ann J Hessell; Boris Julg; Nicole A Doria-Rose; Stephen D Schmidt; Lindsay N Carpp; Michelle D Cully; Xuejun Chen; George M Shaw; Dan H Barouch; Nancy L Haigwood; Lawrence Corey; Dennis R Burton; Mario Roederer; Peter B Gilbert; John R Mascola; Ying Huang
Journal:  Cell Host Microbe       Date:  2019-09-11       Impact factor: 21.023

8.  Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells.

Authors:  Karin Loré; Anna Smed-Sörensen; Jayanand Vasudevan; John R Mascola; Richard A Koup
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

9.  Antibody barriers to going viral.

Authors:  Dennis R Burton
Journal:  J Exp Med       Date:  2019-08-23       Impact factor: 14.307

10.  The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.

Authors:  David C Montefiori; Maria V Filsinger Interrante; Benjamin N Bell; Adonis A Rubio; Joseph G Joyce; John W Shiver; Celia C LaBranche; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779
View more
  3 in total

1.  A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.

Authors:  Panpan Zhou; Meng Yuan; Ge Song; Nathan Beutler; Namir Shaabani; Deli Huang; Wan-Ting He; Xueyong Zhu; Sean Callaghan; Peter Yong; Fabio Anzanello; Linghang Peng; James Ricketts; Mara Parren; Elijah Garcia; Stephen A Rawlings; Davey M Smith; David Nemazee; John R Teijaro; Thomas F Rogers; Ian A Wilson; Dennis R Burton; Raiees Andrabi
Journal:  bioRxiv       Date:  2022-01-21

2.  A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.

Authors:  Panpan Zhou; Meng Yuan; Ge Song; Nathan Beutler; Namir Shaabani; Deli Huang; Wan-Ting He; Xueyong Zhu; Sean Callaghan; Peter Yong; Fabio Anzanello; Linghang Peng; James Ricketts; Mara Parren; Elijah Garcia; Stephen A Rawlings; Davey M Smith; David Nemazee; John R Teijaro; Thomas F Rogers; Ian A Wilson; Dennis R Burton; Raiees Andrabi
Journal:  Sci Transl Med       Date:  2022-03-23       Impact factor: 17.956

3.  A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.

Authors:  Adonis A Rubio; Maria V Filsinger Interrante; Benjamin N Bell; Clayton L Brown; Theodora U J Bruun; Celia C LaBranche; David C Montefiori; Peter S Kim
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.